 Cell Engineering
"Cell Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
| Descriptor ID |
D060846
|
| MeSH Number(s) |
E05.481.500.311 J01.293.069.249
|
| Concept/Terms |
Cell Engineering- Cell Engineering
- Engineering, Cell
- Cellular Engineering
- Engineering, Cellular
|
Below are MeSH descriptors whose meaning is more general than "Cell Engineering".
Below are MeSH descriptors whose meaning is more specific than "Cell Engineering".
This graph shows the total number of publications written about "Cell Engineering" by people in this website by year, and whether "Cell Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2020 | 1 | 2 | 3 | | 2021 | 1 | 0 | 1 | | 2023 | 0 | 2 | 2 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Engineering" by people in Profiles.
-
Padilla MS, Mrksich K, Wang Y, Haley RM, Li JJ, Han EL, El-Mayta R, Kim EH, Dias S, Gong N, Teerdhala SV, Han X, Chowdhary V, Xue L, Siddiqui Z, Yamagata HM, Kim D, Yoon IC, Wilson JM, Radhakrishnan R, Mitchell MJ. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat Commun. 2025 Jan 24; 16(1):996.
-
Billingsley MM, Gong N, Mukalel AJ, Thatte AS, El-Mayta R, Patel SK, Metzloff AE, Swingle KL, Han X, Xue L, Hamilton AG, Safford HC, Alameh MG, Papp TE, Parhiz H, Weissman D, Mitchell MJ. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism. Small. 2024 03; 20(11):e2304378.
-
Hamilton AG, Swingle KL, Joseph RA, Mai D, Gong N, Billingsley MM, Alameh MG, Weissman D, Sheppard NC, June CH, Mitchell MJ. Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering. Adv Healthc Mater. 2023 12; 12(30):e2301515.
-
Guo J, Kent A, Davila E. Chimeric non-antigen receptors in T cell-based cancer therapy. J Immunother Cancer. 2021 08; 9(8).
-
Brusko TM, Russ HA, Stabler CL. Strategies for durable ß cell replacement in type 1 diabetes. Science. 2021 07 30; 373(6554):516-522.
-
Borgers JSW, Haanen JBAG. Cellular Therapy and Cytokine Treatments for Melanoma. Hematol Oncol Clin North Am. 2021 02; 35(1):129-144.
-
Trujillo S, Vega SL, Song KH, San Félix A, Dalby MJ, Burdick JA, Salmeron-Sanchez M. Engineered Full-Length Fibronectin-Hyaluronic Acid Hydrogels for Stem Cell Engineering. Adv Healthc Mater. 2020 11; 9(21):e2000989.
-
Chatterjee A, Cerna Sanchez JA, Yamauchi T, Taupin V, Couvrette J, Gorodetsky AA. Cephalopod-inspired optical engineering of human cells. Nat Commun. 2020 06 02; 11(1):2708.
-
Billingsley MM, Singh N, Ravikumar P, Zhang R, June CH, Mitchell MJ. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering. Nano Lett. 2020 03 11; 20(3):1578-1589.
-
Allen ES, Stroncek DF, Ren J, Eder AF, West KA, Fry TJ, Lee DW, Mackall CL, Conry-Cantilena C. Autologous lymphapheresis for the production of chimeric antigen receptor T cells. Transfusion. 2017 05; 57(5):1133-1141.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|